PAH implant study halted, shifts to patient support
NCT ID NCT01321073
First seen Jan 30, 2026 · Last updated Jun 18, 2026 · Updated 22 times
Summary
This study looked at the safety of a special catheter and pump system implanted in the body to deliver a drug called Remodulin for people with pulmonary arterial hypertension (high blood pressure in the lungs). The study enrolled 64 participants. The company stopped developing the system, so the study now focuses on supporting the roughly 30 people who still have the implant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AdventHealth Orlando
Orlando, Florida, 32803, United States
-
Aurora St. Lukes Medical Center
Milwaukee, Wisconsin, 53234, United States
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-7208, United States
-
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.